U.S. markets closed

Cue Health Inc. (HLTH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.33-0.21 (-1.99%)
At close: 4:00PM EDT
10.25 -0.08 (-0.77%)
After hours: 05:53PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close10.54
Bid10.17 x 1000
Ask10.49 x 900
Day's Range10.09 - 10.60
52 Week Range9.55 - 22.55
Avg. Volume1,841,552
Market Cap1.485B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.35
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HLTH

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cue Health Inc.
    Analyst Report: Omnicom Group Inc.Omnicom is the world’s second-largest ad holding company, based on annual revenue. The American firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
    Fair Value
    Economic Moat
View more

    Koch Industries Invests in Covid-19 Tests, IoT Firm

    Koch Industries disclosed big investments in Cue Health, Kore Group Holdings, and blank-check firm Hennessy Capital Investment Corp. VI.

  • PR Newswire

    Cue Health To Provide COVID-19 Testing For 2021-22 NBA Season

    Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, and the National Basketball Association (NBA) today announced that Cue will serve as the league's Official Home and Point of Care Test for the 2021-22 season. The Cue COVID-19 Test for Home and Over The Counter (OTC) Use is the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without physician supervision or a prescription.

  • Benzinga

    Cue Health, Google Cloud Join Forces To Track Respiratory Viral Variants

    Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Care platform. Cue said it would build Google Cloud's artificial intelligence, machine learning, analytics, and privacy and security tools into its platform, including its Cue Health Monitoring System and rapid molecular COVID-19 test. The COVID-19 test delivers results to mobile devices in approximately 20 minutes. In March, the assay received Emergency